Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Revolve Gr
(NYSE:RVLV)
Intraday
$21.24
-0.42
[-1.94%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$21.24
-0.42
[-1.94%]
Last update: 3:23PM
Get Real Time Here
Get Report
Watch
Q1 2024 Earnings were released on Tue May 7th, after the market close
The most recent conference call was at 16:30 PM, 3 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Revolve Gr Stock (NYSE:RVLV)
Revolve Gr Stock (NYSE: RVLV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 09, 2024
UBS Maintains Neutral on Revolve Gr, Raises Price Target to $22
Benzinga Newsdesk
-
1 day ago
Wednesday, May 08, 2024
Barclays Maintains Underweight on Revolve Gr, Raises Price Target to $15
Benzinga Newsdesk
-
2 days ago
Roth MKM Maintains Buy on Revolve Gr, Raises Price Target to $26
Benzinga Newsdesk
-
2 days ago
BMO Capital Maintains Market Perform on Revolve Gr, Raises Price Target to $15
Benzinga Newsdesk
-
2 days ago
Wedbush Maintains Neutral on Revolve Gr, Raises Price Target to $19
Benzinga Newsdesk
-
2 days ago
Baird Maintains Neutral on Revolve Gr, Raises Price Target to $23
Benzinga Newsdesk
-
2 days ago
Needham Maintains Buy on Revolve Gr, Raises Price Target to $25
Benzinga Newsdesk
-
2 days ago
Tuesday, May 07, 2024
Revolve Group Sees Q2 Gross Margin Of 53.9%-54.4%, Affirms FY24 Forecast Of 52.5% - 53.0%
Benzinga Newsdesk
-
2 days ago
Revolve Gr Q1 2024 GAAP EPS $0.15 Beats $0.07 Estimate, Sales $270.581M Miss $271.831M Estimate
Benzinga Newsdesk
-
2 days ago
Monday, May 06, 2024
Evercore ISI Group Maintains In-Line on Revolve Gr, Raises Price Target to $20
Benzinga Newsdesk
-
4 days ago
Friday, April 26, 2024
What Analysts Are Saying About Revolve Gr Stock
Benzinga Insights
-
Apr 26, 2024, 4:00PM
Stifel Maintains Buy on Revolve Gr, Raises Price Target to $24
Benzinga Newsdesk
-
Apr 26, 2024, 11:27AM
Wednesday, April 10, 2024
11 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Apr 10, 2024, 12:31PM
UBS Maintains Neutral on Revolve Gr, Raises Price Target to $20
Benzinga Newsdesk
-
Apr 10, 2024, 11:25AM
Shares of retail companies are trading lower amid overall market weakness following hotter-than-expected March inflation data.
Benzinga Newsdesk
-
Apr 10, 2024, 10:01AM
Wednesday, April 03, 2024
BTIG Maintains Buy on Revolve Gr, Raises Price Target to $24
Benzinga Newsdesk
-
Apr 3, 2024, 10:42AM
Thursday, March 21, 2024
Analyst Ratings For Revolve Gr
Benzinga Insights
-
Mar 21, 2024, 9:00AM
Revolve Group shares are trading higher after TD Cowen upgraded the stock from Market Perform to Outperform and raised its price target from $23 to $25.
Benzinga Newsdesk
-
Mar 21, 2024, 6:56AM
TD Cowen Upgrades Revolve Gr to Outperform, Raises Price Target to $25
Benzinga Newsdesk
-
Mar 21, 2024, 5:58AM
Thursday, February 29, 2024
Barclays Maintains Underweight on Revolve Gr, Raises Price Target to $13
Benzinga Newsdesk
-
Feb 29, 2024, 8:33AM
12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Feb 29, 2024, 8:07AM
Wednesday, February 28, 2024
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Feb 28, 2024, 2:02PM
Evercore ISI Group Maintains In-Line on Revolve Gr, Raises Price Target to $17
Benzinga Newsdesk
-
Feb 28, 2024, 12:25PM
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Feb 28, 2024, 11:37AM
Piper Sandler Maintains Overweight on Revolve Gr, Raises Price Target to $22.5
Benzinga Newsdesk
-
Feb 28, 2024, 10:36AM
Revolve Group shares are trading higher after the company reported better-than-expected Q4 financial results.
Benzinga Newsdesk
-
Feb 28, 2024, 9:19AM
These Analysts Boost Their Forecasts On Revolve Group After Q4 Earnings
Avi Kapoor
-
Feb 28, 2024, 8:30AM
Wedbush Maintains Neutral on Revolve Gr, Raises Price Target to $17
Benzinga Newsdesk
-
Feb 28, 2024, 8:11AM
Raymond James Upgrades Revolve Gr to Outperform, Announces $21 Price Target
Benzinga Newsdesk
-
Feb 28, 2024, 6:40AM
Needham Maintains Buy on Revolve Gr, Raises Price Target to $23
Benzinga Newsdesk
-
Feb 28, 2024, 5:41AM
Tuesday, February 27, 2024
Recap: Revolve Gr Q4 Earnings
Benzinga Insights
-
Feb 27, 2024, 4:35PM
Revolve Gr Q4 2023 GAAP EPS $0.05 Beats $0.02 Estimate, Sales $257.78M Beat $246.38M Estimate
Benzinga Newsdesk
-
Feb 27, 2024, 4:31PM
Earnings Scheduled For February 27, 2024
Benzinga Insights
-
Feb 27, 2024, 5:01AM
Friday, February 23, 2024
Evaluating Revolve Gr: Insights From 7 Financial Analysts
Benzinga Insights
-
Feb 23, 2024, 10:01AM
Wednesday, January 17, 2024
Why This Revolve Group Analyst Is Turning Bullish
Priya Nigam
-
Jan 17, 2024, 11:59AM
Piper Sandler Upgrades Revolve Gr to Overweight, Raises Price Target to $21
Benzinga Newsdesk
-
Jan 17, 2024, 5:29AM
Wednesday, January 10, 2024
Expert Ratings For Revolve Gr
Benzinga Insights
-
Jan 10, 2024, 8:00AM
Goldman Sachs Initiates Coverage On Revolve Gr with Sell Rating, Announces Price Target of $12
Benzinga Newsdesk
-
Jan 10, 2024, 7:07AM
Thursday, January 04, 2024
Baird Downgrades Revolve Gr to Neutral, Announces $17 Price Target
Benzinga Newsdesk
-
Jan 4, 2024, 8:00AM
Jefferies Downgrades Revolve Gr to Hold, Announces $17 Price Target
Benzinga Newsdesk
-
Jan 4, 2024, 7:56AM
Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
-
Jan 4, 2024, 5:46AM
Wednesday, December 20, 2023
Roth MKM Maintains Buy on Revolve Gr, Raises Price Target to $21
Benzinga Newsdesk
-
Dec 20, 2023, 10:01AM
Thursday, December 14, 2023
Stifel Maintains Buy Rating for Revolve Gr: Here's What You Need To Know
Benzinga Insights
-
Dec 14, 2023, 12:00PM
What 10 Analyst Ratings Have To Say About Revolve Gr
Benzinga Insights
-
Dec 14, 2023, 12:00PM
Stifel Maintains Buy on Revolve Gr, Raises Price Target to $18
Benzinga Newsdesk
-
Dec 14, 2023, 9:27AM
Tuesday, November 07, 2023
Evercore ISI Group Initiates Coverage On Revolve Gr with In-Line Rating, Announces Price Target of $14
Benzinga Newsdesk
-
Nov 7, 2023, 4:49AM
Friday, November 03, 2023
Analyst Expectations for Revolve Gr's Future
Benzinga Insights
-
Nov 3, 2023, 3:00PM
Thursday, November 02, 2023
Piper Sandler Maintains Neutral on Revolve Gr, Lowers Price Target to $16
Benzinga Newsdesk
-
Nov 2, 2023, 4:23PM
BMO Capital Maintains Market Perform on Revolve Gr, Lowers Price Target to $13
Benzinga Newsdesk
-
Nov 2, 2023, 3:12PM
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 2, 2023, 2:26PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch